Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1.91
- Piotroski Score 2.00
- Grade Buy
- Symbol (ARTL)
- Company Artelo Biosciences, Inc.
- Price $1.16
- Changes Percentage (-3.75%)
- Change -$0.05
- Day Low $1.12
- Day High $1.22
- Year High $1.75
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.16
- Trailing P/E Ratio -0.44
- Forward P/E Ratio -0.44
- P/E Growth -0.44
- Net Income $-9,874,000
Income Statement
Quarterly
Annual
Latest News of ARTL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Point72 Japan Head Bartlett to Step Down, Firm Seeks Successor
Toby Bartlett, head of Japan at Point72 Asset Management, is stepping down. He will transition to a consulting role for the firm. Point72 is searching for his replacement as they continue to expand in...
By Yahoo! Finance | 1 day ago -
NBA fans mock LaMelo Ball for knocking the head off a clown after getting startled by Halloween prop
Paul Pierce, Keyshawn Johnson, and Joy Taylor discuss LeBron and Bronny James being the first father-son duo in the NBA. LaMelo Ball's Halloween prank reaction went viral as he knocked off a clown's h...
By Fox News | 1 week ago -
The Heartland Express, Inc. (NASDAQ:HTLD) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Heartland Express, Inc. recently reported disappointing quarterly results, missing revenue predictions and posting a larger loss per share. Analysts have adjusted their forecasts, anticipating slower ...
By Yahoo! Finance | 1 week ago
